Oracle Power (ORCP), the international natural resources project developer, announced that further positive metallurgical results have been returned from the three samples from its 100% owned Northern Zone Gold Project,
Evgen Pharma PLC (EVG.L) Progress with UK and US regulators for 2022 trials
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of cancers and inflammation, announces that it has progressed discussions with the
Traders Cafe with Zak Mir: TGR, BRSD, VLS, NTQ, EVG, IGE, EML, DKL, POW, KEFI, ZED, FAR, VAST, KDR, ZOO & BVC via Vox Markets
It would appear that there is something of a land grab going on for Tirupati Graphite (TGR), the specialist graphite producer.
Share Talk Weekly Stock Market News, Sunday 26th September 2021
The AIM All-Share fell 0.7% over the week in the small-cap market. This was lower than the FTSE 100 which grew 1.3 percent.
Evgen Pharma PLC (EVG.L) Publication of data in glioblastoma cells
Publication shows effectiveness of SFX-01 in patient derived glioblastoma cells University of Auckland data
Traders Cafe with Zak Mir: ORPH, POLB, RBW, SLE, BZT, MIRI, EVG, CIZ, MHC, SHG, CMRS, IGAS, EUA & SSE via Vox Markets
There was two for the price of one at pharma services group Open Orphan (ORPH), not only its hVIVO subsidiary signing a £5.7m contract with a specialist biotechnology company developing
Traders’ Cafe with Zak Mir: XTR, SEC, OBE, EVG, 88E, ASLR, AAA, BOOM & DEV via Vox Markets
Xtract Resources (XTR) continued its series of progress reports from its Bushranger copper-gold porphyry exploration project in New South Wales. Here the angled holes BRDD-21-013 and 014 of the Phase
Share Talk Weekly Stock Market News, Sunday 18th July 2021
Visit Share Talk TV for a chance to catch up with the previous weeks stock market interviews, and articles made public across multiple platforms including Share Talk, Vox Markets, Proactive Investors. We will expand
Evgen Pharma PLC (EVG.L) Early data for SFX-01 in leukaemia cell lines
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, announces preclinical data demonstrating that SFX-01 was effective in
Share Talk Weekly Small-Cap Report – July 10th 2021
We begin our weekly small company report with news that Yu Group PLC’s (LON:YU.) business update was well received by the market.
Evgen Pharma PLC (EVG.L) Progress with Glioma/Glioblastoma programme
Evgen Pharma plc (AIM: EVG), a clinical stage drug development company, announces further progress and an update on clinical trial plans for SFX-01 in glioblastoma (“GBM”).
